Helicos BioSciences (HLCS) Sells Genetic Analysis System to Dutch Research Collaborative

November 17, 2009 7:50 AM EST

Helicos BioSciences Corporation (NASDAQ: HLCS), today announced the sale of a Helicos Genetic Analysis System to a collaborative Dutch research group led by the Leiden University Medical Center (LUMC), further including the medical centers of Amsterdam (AMC) Groningen (UMCG) and Rotterdam (Erasmus MC) and funded by a grant from NWO, the Netherlands Organization of Scientific Research. The system will be installed at the Leiden Genome Technology Center (LGTC), headed by Professor Johan den Dunnen, a leader in the fields of genomic research and technology.

"We are very proud to have LUMC as a customer. They have a strong tradition of adopting breakthrough technologies and have seen the unique benefits of single molecule analysis first-hand." stated Ron Lowy, Helicos Chief Executive Officer.


Related Categories

Corporate News

Stocks Mentioned

HLCS 1.00

-0.01 -0.99%
Volume: 243,608
Track HLCS


Add Your Comment





Follow StreetInsider.com On Twitter